Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Retrospective Analysis of Drug Disposition and Response-related Genotypes in Cancer Patients and Correlation With Pharmacokinetics and Pharmacodynamics Data
Sponsor: National Cancer Institute (NCI)
Listed as NCT00341939, this observational or N/A phase trial focuses on Breast Cancer and Cutaneous T-Cell Lymphoma and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 48 times since 2004, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
48 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting
-
May 2024 — Jun 2024 [monthly]
Active Not Recruiting
-
Mar 2024 — May 2024 [monthly]
Active Not Recruiting
▶ Show 43 earlier versions
-
Feb 2024 — Mar 2024 [monthly]
Active Not Recruiting
-
Sep 2023 — Feb 2024 [monthly]
Active Not Recruiting
-
Aug 2023 — Sep 2023 [monthly]
Active Not Recruiting
-
Jun 2023 — Aug 2023 [monthly]
Active Not Recruiting
-
May 2023 — Jun 2023 [monthly]
Active Not Recruiting
-
Apr 2023 — May 2023 [monthly]
Active Not Recruiting
-
Feb 2023 — Apr 2023 [monthly]
Active Not Recruiting
-
Dec 2022 — Feb 2023 [monthly]
Active Not Recruiting
-
Nov 2022 — Dec 2022 [monthly]
Active Not Recruiting
-
Sep 2022 — Nov 2022 [monthly]
Active Not Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Active Not Recruiting
-
Jun 2022 — Jul 2022 [monthly]
Active Not Recruiting
-
May 2022 — Jun 2022 [monthly]
Active Not Recruiting
-
Apr 2022 — May 2022 [monthly]
Active Not Recruiting
-
Mar 2022 — Apr 2022 [monthly]
Active Not Recruiting
-
Feb 2022 — Mar 2022 [monthly]
Active Not Recruiting
-
Jan 2022 — Feb 2022 [monthly]
Active Not Recruiting
-
Sep 2021 — Jan 2022 [monthly]
Active Not Recruiting
-
Apr 2021 — Sep 2021 [monthly]
Active Not Recruiting
-
Mar 2021 — Apr 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Dec 2020 [monthly]
Active Not Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Active Not Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Active Not Recruiting
-
Aug 2020 — Sep 2020 [monthly]
Active Not Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Active Not Recruiting
-
Jun 2020 — Jul 2020 [monthly]
Active Not Recruiting
-
May 2020 — Jun 2020 [monthly]
Active Not Recruiting
-
Apr 2020 — May 2020 [monthly]
Active Not Recruiting
-
Mar 2020 — Apr 2020 [monthly]
Active Not Recruiting
-
Dec 2019 — Mar 2020 [monthly]
Active Not Recruiting
-
Oct 2019 — Dec 2019 [monthly]
Active Not Recruiting
-
Sep 2019 — Oct 2019 [monthly]
Active Not Recruiting
-
Jan 2019 — Sep 2019 [monthly]
Active Not Recruiting
-
Oct 2018 — Jan 2019 [monthly]
Active Not Recruiting
Status: Completed → Active Not Recruiting
-
Sep 2018 — Oct 2018 [monthly]
Completed
-
Jun 2018 — Sep 2018 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
Completed NA
-
May 2017 — Jun 2017 [monthly]
Completed NA
-
Jan 2017 — May 2017 [monthly]
Completed NA
First recorded
Sep 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .